Resources search

Global polio eradication initiative : annual report 2008

WORLD HEALTH ORGANIZATION (WHO)
2009

Expand view

This is the annual report of the Global Polio Eradication Initiative (GPEI) measuring progress made in 2008 against the objectives of the GPEI Strategic Plan 2004-2008 and against milestones set for the current Intensified Eradication Effort 2007-2008. Set up in 1988, the GPEI is spearheaded by WHO, Rotary International, CDC and UNICEF

Measuring transparency to improve good governance in the public pharmaceutical sector : Jordan

NUSEIRAT, Adi
2009

Expand view

"This report presents the findings of the first phase of the [World Health Organization's] national Good Governance for Medicines programme in Jordan. The assessment aims to obtain a picture of the level of transparency and potential vulnerability to corruption in the public pharmaceutical sector using WHO’s assessment instrument. In Jordan, the assessment looked at six functions: medicines registration, inspection of pharmaceutical establishments, promotion, selection, procurement and distribution"

Measuring transparency to improve good governance in the public pharmaceutical sector : Lebanon

HAMRA, Rasha
RAIDY, Collette
NAOUS, Maha
2009

Expand view

"This report presents the findings of the first phase of the [World Health Organization's] national Good Governance for Medicines programme in Lebanon. The assessment aims to obtain a picture of the level of transparency and potential vulnerability to corruption in the public pharmaceutical sector using WHO’s assessment instrument. In Lebanon, the assessment looked at six functions: medicines registration, inspection of pharmaceutical establishments, promotion, selection, procurement and distribution"

Measuring transparency to improve good governance in the public pharmaceutical sector : Syrian Arab Republic

AL MARDINI, Amer
AL HAKEEM, Souheila
2009

Expand view

"This report presents the findings of the first phase of the [World Health Organization's] national Good Governance for Medicines programme in the Syrian Arab Republic. The assessment aims to obtain a picture of the level of transparency and potential vulnerability to corruption in the public pharmaceutical sector using WHO’s assessment instrument. In the Syrian Arab Republic, the assessment looked at eight functions: medicines registration, licensing of pharmaceutical establishments, inspection of pharmaceutical establishments, promotion, selection, clinical trials, procurement and distribution"

E-bulletin